Stem Cell Therapy for Sequestration of Traumatic Brain Injury-Induced Inflammation

Int J Mol Sci. 2022 Sep 7;23(18):10286. doi: 10.3390/ijms231810286.

Abstract

Traumatic brain injury (TBI) is one of the leading causes of long-term neurological disabilities in the world. TBI is a signature disease for soldiers and veterans, but also affects civilians, including adults and children. Following TBI, the brain resident and immune cells turn into a "reactive" state, characterized by the production of inflammatory mediators that contribute to the development of cognitive deficits. Other injuries to the brain, including radiation exposure, may trigger TBI-like pathology, characterized by inflammation. Currently there are no treatments to prevent or reverse the deleterious consequences of brain trauma. The recognition that TBI predisposes stem cell alterations suggests that stem cell-based therapies stand as a potential treatment for TBI. Here, we discuss the inflamed brain after TBI and radiation injury. We further review the status of stem cells in the inflamed brain and the applications of cell therapy in sequestering inflammation in TBI.

Keywords: brain repair; inflammation; neurogenesis; resident stem cells; stem cell-based therapy; trauma; traumatic brain injury.

Publication types

  • Review

MeSH terms

  • Adult
  • Brain Injuries, Traumatic* / pathology
  • Child
  • Cognition Disorders*
  • Humans
  • Inflammation / etiology
  • Inflammation / therapy
  • Inflammation Mediators
  • Stem Cell Transplantation

Substances

  • Inflammation Mediators

Grants and funding

This work was supported by National Institutes of Health grants R01CA133216, R01CA213441 and R01AG056770 (S.R.) and NASA grants NNX14AC94G (S.R.) and 80NSSC19K1581 (S.R.).